CHP GmbH is a medical technology company and medical product manufacturer based in Düsseldorf. It is involved in the research and development of innovative stimulation methods for the cellular control of inflammation and regeneration. The Axomera therapy developed by CHP is used by medical specialists in Europe for the conservative treatment of pain disorders, musculoskeletal disorders and in sports medicine. CHP cooperates with clinicians and researchers at the Universities of Aberdeen – Scotland (basic research) and Hannover, Tübingen, Greiswald to conduct clinical randomised multicentre trials.

Axomera is a brand of Columbus Health Products (CHP) GmbH.

Founders

Prof. Dr. med. Albrecht Molsberger, Specialist for Orthopaedics and Pain, Ruhr University Bochum and Private Clinic Düsseldorf – (CEO)

Dr. med. Gabriele Boewing, Specialist for Internal Medicine and Rheumatology, Düsseldorf – (CMO)

Dr. med. Philipp Schröder: Physician – Private Clinic Düsseldorf, Düsseldorf – (COO, Prokurist)

Contact

Kasernenstr 1b , 40213 Düsseldorf. 

Phone: +49 (0) 211 15806330. 

Fax: +49 (0) 211 15209962

E-mail: [email protected]

HRB 32326